M. CAN Et Al. , "AB0543 CONVENTIONAL DMARD THERAPY METHOTREXATE SULPHASALAZINE MAY DECREASE THE SWITCH TO BIOLOGICS IN ROUTINE PRACTICE OF ANKYLOSING SPONDYLITIS PATIENTS," EULAR 2010 Rome, Italy , 2010
CAN, M. Et Al. 2010. AB0543 CONVENTIONAL DMARD THERAPY METHOTREXATE SULPHASALAZINE MAY DECREASE THE SWITCH TO BIOLOGICS IN ROUTINE PRACTICE OF ANKYLOSING SPONDYLITIS PATIENTS. EULAR 2010 Rome, Italy .
CAN, M., AYDIN, S. Z., Niğdelioğlu, A., DİRESKENELİ, R. H., & ATAGÜNDÜZ, M. P., (2010). AB0543 CONVENTIONAL DMARD THERAPY METHOTREXATE SULPHASALAZINE MAY DECREASE THE SWITCH TO BIOLOGICS IN ROUTINE PRACTICE OF ANKYLOSING SPONDYLITIS PATIENTS . EULAR 2010 Rome, Italy
CAN, Meryem Et Al. "AB0543 CONVENTIONAL DMARD THERAPY METHOTREXATE SULPHASALAZINE MAY DECREASE THE SWITCH TO BIOLOGICS IN ROUTINE PRACTICE OF ANKYLOSING SPONDYLITIS PATIENTS," EULAR 2010 Rome, Italy, 2010
CAN, Meryem Et Al. "AB0543 CONVENTIONAL DMARD THERAPY METHOTREXATE SULPHASALAZINE MAY DECREASE THE SWITCH TO BIOLOGICS IN ROUTINE PRACTICE OF ANKYLOSING SPONDYLITIS PATIENTS." EULAR 2010 Rome, Italy , 2010
CAN, M. Et Al. (2010) . "AB0543 CONVENTIONAL DMARD THERAPY METHOTREXATE SULPHASALAZINE MAY DECREASE THE SWITCH TO BIOLOGICS IN ROUTINE PRACTICE OF ANKYLOSING SPONDYLITIS PATIENTS." EULAR 2010 Rome, Italy .
@conferencepaper{conferencepaper, author={Meryem CAN Et Al. }, title={AB0543 CONVENTIONAL DMARD THERAPY METHOTREXATE SULPHASALAZINE MAY DECREASE THE SWITCH TO BIOLOGICS IN ROUTINE PRACTICE OF ANKYLOSING SPONDYLITIS PATIENTS}, congress name={EULAR 2010 Rome, Italy}, city={}, country={}, year={2010}}